Cargando…
Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease
There have been increasing number of reports of SZT2-related neurological diseases, the main symptoms of which are epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum. SZT2 functions as a regulator of mechanistic target of rapamycin complex 1 (mTORC1) signaling in cultured h...
Autores principales: | Nakamura, Yuji, Kato, Kohji, Tsuchida, Naomi, Matsumoto, Naomichi, Takahashi, Yoshiyuki, Saitoh, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701784/ https://www.ncbi.nlm.nih.gov/pubmed/31430354 http://dx.doi.org/10.1371/journal.pone.0221482 |
Ejemplares similares
-
SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation
por: Yin, Na, et al.
Publicado: (2022) -
Correction to: mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion
Publicado: (2023) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Insight into Genetic Mutations of SZT2: Is It a Syndrome?
por: Muthaffar, Osama Y., et al.
Publicado: (2023)